As pharmaceutical industry retreats, research and development for tuberculosis treatments, diagnostics and prevention relies more than ever on government support, and it’s dropping, Treatment Action Group report shows . . . LIVERPOOL, England – The chance to have the right people and the right information in the right place at the same time comes all too rarely […]
LIVERPOOL, England – While much of the focus at this conference focuses on the pursuit of new knowledge, to better treat, diagnose and prevent tuberculosis, a group of experts from leading institutions worldwide have put together everything they currently know about the disease in 23 pages. Among the points, lead author Madhukar Pai said today, as […]
HIV
The following is a guest post By Sharon Weir, Ph.D. of MEASURE Evaluation For almost 35 years, HIV/AIDS has been a household word across the globe. […]
Tuberculosis
In 2017, around the world as many as 4,000 people died of tuberculosis on any given day. That added up to an estimated — give or […]
Research & Development
A trial to test the safety of, and immune response prompted by, the latest candidate for a vaccine to protect against Zika virus infection has begun […]
Policy
The following is a guest post by Michelle Li of MEASURE Evaluation At MEASURE Evaluation, funded by the United States Agency for International Development, we work […]